Regulación de la liberación de renina durante la hipertensión renovascular
Resumen
Texto completo:
PDFReferencias
Lawes CM, Vander-Hoorn S, Rodgers A. International Society of Hypertension. Global burden of blood-pressure-related disease 2001. Lancet. 2008; 371(9623): 1513–1518.
Instituto Nacional de la Salud Pública. Secretaría de Salud. Encuesta Nacional de Salud y Nutrición. 2012. Resultados Nacionales. México: 113-116.
Stern RH. The new hypertension guidelines. J Clin Hypertens (Greenwich). 2013 Oct; 15(10): 748-51.
Coffman TM. The inextricable role of the kidney in hypertension. J Clin Invest. 2014 Jun; 124(6): 2341-7.
Ivy JR, Bailey MA. Pressure natriuresis and the renal control of arterial blood pressure. J Physiol. 2014 Sep 15; 592(Pt 18): 3955-67.
Chen D, Coffman TM. The kidney and hypertension: lessons from mouse models. Can J Cardiol. 2012 May; 28(3): 305-10
Powers B, Greene L, Balfe LM. Updates on the treatment of essential hypertension: a summary of AHRQ's comparative effectiveness review of angiotensin-converting enzyme inhibitors, angiotensin II receptor blockers, and direct renin inhibitors. J Manag Care Pharm. 2011 Oct; 17(8 Suppl): S1-14.
Navar LG, Kobori H, Prieto MC, Gonzalez-Villalobos RA. Intratubular renin-angiotensin system in hypertension. Hypertension. 2011 Mar; 57(3): 355–362.
Navar LG, Prieto MC, Satou R, Kobori H. Intrarenal angiotensin II and its contribution to the genesis of chronic hypertension. Curr Opin Pharmacol. 2011 Apr; 11(2): 180-6.
Matsusaka T, Niimura F, Shimizu A, Pastan I, Saito A, Kobori H, et al. Liver angiotensinogen is the primary source of renal angiotensin II. J Am Soc Nephrol. 2012 Jul; 23(7): 1181-9.
Navar LG, Harrison-Bernard LM, Wang CT, Cervenka L, Mitchell KD. Concentrations and actions of intraluminal angiotensin II. J Am Soc Nephrol. 1999 Jan; 10 (Suppl11): S189–95.
Crowley SD, Zhang J, Herrera M, Griffiths R, Ruiz P, Coffman TM. Role of AT1 receptor-mediated salt retention in angiotensin II dependent hypertension. Am J Physiol Renal Physiol. 2011 Nov; 301(5): F1124-30.
Ohsawa M, Tamura K, Wakui H, Maeda A, Dejima T, Kanaoka T. Deletion of the angiotensin II type 1 receptor-associated protein enhances renal sodium reabsorption and exacerbates angiotensin II-mediated hypertension. Kidney Int. 2014 Sep; 86(3): 570-81.
Enlaces refback
- No hay ningún enlace refback.